Title |
Genetic mutations in the treatment of anaplastic thyroid cancer: a systematic review
|
---|---|
Published in |
BMC Surgery, October 2013
|
DOI | 10.1186/1471-2482-13-s2-s44 |
Pubmed ID | |
Authors |
Anna Guerra, Vincenzo Di Crescenzo, Alfredo Garzi, Mariapia Cinelli, Chiara Carlomagno, Massimo Tonacchera, Pio Zeppa, Mario Vitale |
Abstract |
Anaplastic thyroid cancer (ATC) is a rare, lethal disease associated with a median survival of 6 months despite the best multidisciplinary care. Surgical resection is not curative in ATC patients, being often a palliative procedure. Multidisciplinary care may include surgery, loco-regional radiotherapy, and systemic therapy. Besides conventional chemotherapy, multi kinase-targeted inhibitors are emerging as novel therapeutic tools. The numerous molecular alteration detected in ATC are targets for these inhibitors. The aim of this review is to determine the prevalence of the major genetic alterations occurring in ATC and place the results in the context of the emerging kinase-targeted therapies. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Portugal | 1 | 2% |
Unknown | 54 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 12 | 22% |
Student > Ph. D. Student | 10 | 18% |
Other | 6 | 11% |
Student > Bachelor | 5 | 9% |
Student > Master | 4 | 7% |
Other | 7 | 13% |
Unknown | 11 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 20 | 36% |
Biochemistry, Genetics and Molecular Biology | 10 | 18% |
Agricultural and Biological Sciences | 8 | 15% |
Immunology and Microbiology | 1 | 2% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 2% |
Other | 2 | 4% |
Unknown | 13 | 24% |